Table 2 Characteristics of participants of the survey
Participant characteristics (number of responses) | Number of participants (% of response) |
|---|---|
Number of participants | |
Total | 556 (100) |
Completed survey | 350 (62.9) |
Ineligible (Do not use evidence syntheses for decision-making purposes)a | 16 |
Ineligible (Opt-out for all three scenarios) | 9 |
Eligible | 325 (58.5) |
Gender (n = 323)b | |
Female | 165 (51.1) |
Male | 158 (48.9) |
Age – years (n = 323)b | |
21 – 30 | 15 (4.6) |
31 – 40 | 75 (23.2) |
41 – 50 | 92 (28.5) |
51 – 60 | 109 (33.8) |
61 – 70 | 29 (9.0) |
> 70 | 3 (0.9) |
Selected survey language (n = 325) | |
English | 136 (41.9) |
Spanish | 104 (32.0) |
German | 85 (26.1) |
Type of user of evidence (n = 325)c | |
Guideline developer | 143 (44.0) |
Health policy decisionmaker | 68 (20.9) |
Decisionmaker in a health insurance company | 41 (12.6) |
Decisionmaker in a regulatory agency | 19 (5.9) |
Hospital administrator | 16 (4.9) |
Other | 120 (36.9) |
Residence by continents with most commonly reported countries (n = 325) | |
Europe | 147 (45.2) |
Austria | 53 (16.3) |
United Kingdom | 47 (14.5) |
Germany | 31 (9.5) |
South and Central America | 114 (35.1) |
Argentina | 45 (13.9) |
Peru | 18 (5.5) |
Colombia | 17 (5.2) |
North America | 57 (17.5) |
Canada | 33 (10.2) |
United States of America | 24 (7.4) |
Africa | 3 (0.9) |
Australia and New Zealand | 3 (0.9) |
Asia | 1 (0.3) |